Clinical Characteristics, Laboratory Identification, and In Vitro Antifungal Susceptibility of Yarrowia (Candida) lipolytica Isolates Causing Fungemia: a Multicenter, Prospective Surveillance Study
Author(s) -
Ying Zhao,
Jasper FukWoo Chan,
ChiChing Tsang,
He Wang,
Da-Wen Guo,
Yuhong Pan,
Yuling Xiao,
Na Yue,
Jonathan Hon-Kwan Chen,
Susanna K. P. Lau,
Yingchun Xu,
Patrick C. Y. Woo
Publication year - 2015
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.01985-15
Subject(s) - yarrowia , fungemia , microbiology and biotechnology , voriconazole , biology , amphotericin b , internal transcribed spacer , candida tropicalis , echinocandins , ribosomal rna , candida albicans , antifungal , caspofungin , gene , genetics
Our case series showed that uncomplicated Yarrowia lipolytica fungemia might be treated with catheter removal alone. The Vitek 2 YST identification (ID) card system, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), and internal transcribed spacer and 25S nuclear ribosomal DNA (nrDNA) gene sequencing provided reliable identification. All isolates had low MICs to voriconazole, echinocandins, and amphotericin B.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom